T. Lammers
Molecular Biology · 2012–2020
A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 119 citations into it
- Biomedical Engineering — 88 citations into it
- Cancer Research — 46 citations into it
Whom T. Lammers trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts T. Lammers overall
Papers from T. Lammers's perspective
Ordered by how strongly the researchers T. Lammers trusts endorse each paper. Same corpus, a different order for every researcher.
- Pathology: Cancer cells compress intratumour vessels (Nature)
- Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. (Cancer Research)
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors (Proceedings of the National Academy of Sciences of the United States of America)
- Openings between defective endothelial cells explain tumor vessel leakiness. (American Journal of Pathology)
- Ligand-targeted therapeutics in anticancer therapy (Nature Reviews. Cancer)
- Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels (Nature Communications)
- Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors (Cancer Research)
- The hallmarks of cancer (RNA Biology)
- Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation (Nature Medicine)
- Hallmarks of cancer: the next generation. (Cell)
Their papers
- Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. (2012) — 1,266 citations
- Smart cancer nanomedicine: Strategic directions to improve translation and exploitation (2019) — 966 citations
- Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine (2019) — 381 citations
- Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. (2017) — 1,049 citations
- The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy (2020) — 698 citations
- Iron Oxide Nanoparticles: Diagnostic, Therapeutic and Theranostic Applications (2019) — 938 citations
- Tumor Targeting via EPR: Strategies to Enhance Patient Responses (2018) — 1,055 citations